BACKGROUND: Intentional laceration of the anterior mitral leaflet (LAMPOON) is an effective adjunct to transcatheter mitral valve replacement that prevents left ventricular outflow tract (LVOT) obstruction. To date, LAMPOON has been performed in over 150 patients using a retrograde approach that can be technically challenging. A modified antegrade transseptal technique may simplify the procedure. METHODS: Antegrade LAMPOON was developed and tested in nonsurvival pig experiments. Thereafter, antegrade LAMPOON was performed in patients at prohibitive risk of LVOT obstruction. Clinical, procedural, and angiographic details were abstracted from medical records of their index procedure, and were compared with findings in comparable patients at risk of fixed-LVOT obstruction in the LAMPOON investigational device exemption trial. RESULTS: Eight patients at risk of fixed LVOT obstruction underwent antegrade LAMPOON. Leaflet traversal and laceration were technically successful in all. There were no cases of clinically significant LVOT obstruction (mean LVOT gradient at discharge: 5.4±1.4 mm Hg). One patient suffered a ventricular wire perforation, unrelated to the antegrade LAMPOON technique, and did not survive to discharge. At the time of discharge, no patients had an increase of >10 mm Hg in LVOT gradient compared with baseline. Procedure times (from traversal to transcatheter mitral valve replacement) were shorter, compared with the retrograde technique in the LAMPOON investigational device exemption trial (39±09 versus 65±35 minutes). All patients survived (8/8, 100%) the procedure, and 7/8 (88%) survived to 30 days, similar to subjects in the LAMPOON investigational device exemption trial. CONCLUSIONS: Antegrade LAMPOON is an effective, reproducible, and simplified strategy to lacerate the anterior leaflet before transcatheter mitral valve replacement. The authors recommend the technique as the new standard for LAMPOON.
BACKGROUND: Intentional laceration of the anterior mitral leaflet (LAMPOON) is an effective adjunct to transcatheter mitral valve replacement that prevents left ventricular outflow tract (LVOT) obstruction. To date, LAMPOON has been performed in over 150 patients using a retrograde approach that can be technically challenging. A modified antegrade transseptal technique may simplify the procedure. METHODS: Antegrade LAMPOON was developed and tested in nonsurvival pig experiments. Thereafter, antegrade LAMPOON was performed in patients at prohibitive risk of LVOT obstruction. Clinical, procedural, and angiographic details were abstracted from medical records of their index procedure, and were compared with findings in comparable patients at risk of fixed-LVOT obstruction in the LAMPOON investigational device exemption trial. RESULTS: Eight patients at risk of fixed LVOT obstruction underwent antegrade LAMPOON. Leaflet traversal and laceration were technically successful in all. There were no cases of clinically significant LVOT obstruction (mean LVOT gradient at discharge: 5.4±1.4 mm Hg). One patient suffered a ventricular wire perforation, unrelated to the antegrade LAMPOON technique, and did not survive to discharge. At the time of discharge, no patients had an increase of >10 mm Hg in LVOT gradient compared with baseline. Procedure times (from traversal to transcatheter mitral valve replacement) were shorter, compared with the retrograde technique in the LAMPOON investigational device exemption trial (39±09 versus 65±35 minutes). All patients survived (8/8, 100%) the procedure, and 7/8 (88%) survived to 30 days, similar to subjects in the LAMPOON investigational device exemption trial. CONCLUSIONS: Antegrade LAMPOON is an effective, reproducible, and simplified strategy to lacerate the anterior leaflet before transcatheter mitral valve replacement. The authors recommend the technique as the new standard for LAMPOON.
Authors: Gregg W Stone; David H Adams; William T Abraham; Arie Pieter Kappetein; Philippe Généreux; Pascal Vranckx; Roxana Mehran; Karl-Heinz Kuck; Martin B Leon; Nicolo Piazza; Stuart J Head; Gerasimos Filippatos; Alec S Vahanian Journal: Eur Heart J Date: 2015-07-13 Impact factor: 29.983
Authors: Vasilis C Babaliaros; Adam B Greenbaum; Jaffar M Khan; Toby Rogers; Dee Dee Wang; Marvin H Eng; William W O'Neill; Gaetano Paone; Vinod H Thourani; Stamatios Lerakis; Dennis W Kim; Marcus Y Chen; Robert J Lederman Journal: JACC Cardiovasc Interv Date: 2017-04-24 Impact factor: 11.195
Authors: Jaffar M Khan; Vasilis C Babaliaros; Adam B Greenbaum; Jason R Foerst; Shahram Yazdani; James M McCabe; Gaetano Paone; Marvin H Eng; Bradley G Leshnower; Patrick T Gleason; Marcus Y Chen; Dee Dee Wang; Xin Tian; Annette M Stine; Toby Rogers; Robert J Lederman Journal: J Am Coll Cardiol Date: 2019-05-28 Impact factor: 24.094
Authors: Adam B Greenbaum; Jose F Condado; Marvin Eng; Stamatios Lerakis; Dee Dee Wang; Dennis W Kim; Robert J Lederman; Gaetano Paone; William W O Neill; Vinod H Thourani; Vasilis C Babaliaros Journal: Catheter Cardiovasc Interv Date: 2017-05-04 Impact factor: 2.692
Authors: Dee Dee Wang; Mayra Guerrero; Marvin H Eng; Mackram F Eleid; Christopher U Meduri; Vivek Rajagopal; Pradeep K Yadav; Michael A Fifer; Igor F Palacios; Charanjit S Rihal; Ted E Feldman; William W O'Neill Journal: JACC Cardiovasc Interv Date: 2019-07-08 Impact factor: 11.195
Authors: Jaffar M Khan; Toby Rogers; William H Schenke; Jonathan R Mazal; Anthony Z Faranesh; Adam B Greenbaum; Vasilis C Babaliaros; Marcus Y Chen; Robert J Lederman Journal: JACC Cardiovasc Interv Date: 2016-09-12 Impact factor: 11.195
Authors: Jaffar M Khan; Toby Rogers; Vasilis C Babaliaros; Melissa Fusari; Adam B Greenbaum; Robert J Lederman Journal: JACC Cardiovasc Imaging Date: 2018-05-16
Authors: Mayra Guerrero; Marina Urena; Dominique Himbert; Dee Dee Wang; Mackram Eleid; Susheel Kodali; Isaac George; Tarun Chakravarty; Moses Mathur; David Holzhey; Ashish Pershad; H Kenith Fang; Daniel O'Hair; Noah Jones; Vaikom S Mahadevan; Nicolas Dumonteil; Josep Rodés-Cabau; Nicolo Piazza; Enrico Ferrari; Daniel Ciaburri; Mohammed Nejjari; Augustin DeLago; Paul Sorajja; Firas Zahr; Vivek Rajagopal; Brian Whisenant; Pinak Bipin Shah; Jan-Malte Sinning; Adam Witkowski; Helene Eltchaninoff; Danny Dvir; Bena Martin; Guilherme F Attizzani; Diego Gaia; Nagela S V Nunes; Amir-Ali Fassa; Faraz Kerendi; Gregory Pavlides; Vijay Iyer; Georges Kaddissi; Christian Witzke; James Wudel; Gregory Mishkel; Bryan Raybuck; Chi Wang; Ron Waksman; Igor Palacios; Alain Cribier; John Webb; Vinnie Bapat; Mark Reisman; Raj Makkar; Martin Leon; Charanjit Rihal; Alec Vahanian; William O'Neill; Ted Feldman Journal: J Am Coll Cardiol Date: 2018-05-01 Impact factor: 24.094
Authors: Emily Perdoncin; Christopher G Bruce; Vasilis C Babaliaros; Dursun Korel Yildirim; Jeremiah P Depta; James M McCabe; Patrick T Gleason; Joe Xie; Kendra J Grubb; Gaetano Paone; Keshav Kohli; Norihiko Kamioka; Jaffar M Khan; Toby Rogers; Robert J Lederman; Adam B Greenbaum Journal: Circ Cardiovasc Interv Date: 2021-10-22 Impact factor: 6.546
Authors: Vasilis C Babaliaros; Robert J Lederman; Patrick T Gleason; Jaffar M Khan; Keshav Kohli; Anurag Sahu; Toby Rogers; Christopher G Bruce; Gaetono Paone; Joe X Xie; Norihiko Kamioka; Jose F Condado; Isida Byku; Emily Perdoncin; John C Lisko; Adam B Greenbaum Journal: JACC Cardiovasc Interv Date: 2021-10-25 Impact factor: 11.195
Authors: Jaffar M Khan; Christopher G Bruce; Adam B Greenbaum; Vasilis C Babaliaros; Andrea E Jaimes; William H Schenke; Rajiv Ramasawmy; Felicia Seemann; Daniel A Herzka; Toby Rogers; Michael A Eckhaus; Adrienne Campbell-Washburn; Robert A Guyton; Robert J Lederman Journal: Circ Cardiovasc Interv Date: 2022-04-05 Impact factor: 7.514
Authors: John C Lisko; Vasilis C Babaliaros; Jaffar M Khan; Norihiko Kamioka; Patrick T Gleason; Gaetano Paone; Isida Byku; Jasleen Tiwana; James M McCabe; Krishna Cherukuri; Ramzi Khalil; David Lasorda; Sachin S Goel; Neal S Kleiman; Michael J Reardon; David V Daniels; Christian Spies; Paul Mahoney; Brian C Case; Brian K Whisenant; Pradeep K Yadav; Jose F Condado; Rachel Koch; Kendra J Grubb; Christopher G Bruce; Toby Rogers; Robert J Lederman; Adam B Greenbaum Journal: JACC Cardiovasc Interv Date: 2021-03-01 Impact factor: 11.195
Authors: Keshav Kohli; Zhenglun Alan Wei; Vahid Sadri; Andrew W Siefert; Philipp Blanke; Emily Perdoncin; Adam B Greenbaum; Jaffar M Khan; Robert J Lederman; Vasilis C Babaliaros; Ajit P Yoganathan; John N Oshinski Journal: Front Cardiovasc Med Date: 2022-06-09
Authors: Manuel Barreiro-Perez; Berenice Caneiro-Queija; Luis Puga; Rocío Gonzalez-Ferreiro; Robert Alarcon; Jose Antonio Parada; Andrés Iñiguez-Romo; Rodrigo Estevez-Loureiro Journal: J Clin Med Date: 2021-12-20 Impact factor: 4.241